Video
Lynlee Burton, head of the Center for Vaccines and Emerging Infectious Diseases at PRA Health Sciences, discusses the significance of short vaccine development timelines on the future development of COVID-19 vaccines.
Pharmacy Times interviewed Lynlee Burton, MBA, head of the Center for Vaccines and Emerging Infectious Diseases at PRA Health Sciences, on the significance of short vaccine development timelines for the future of COVID-19 vaccine development.
During the discussion, Burton explained how COVID-19 vaccine development has impacted the future of vaccine development in the industry, what the future for COVID-19 vaccine development may look like, and any developments or potential approvals in the vaccine space of note on the horizon.